Top medical professionals and doctors from the kingdom and beyond will gather under one roof for the Bahrain International Women’s Health Conference and Exhibition in July.
The third edition, which will run from July 3 to 4 at the Diplomat Radisson Blu Hotel, Residence and Spa, Manama, will stage discussions and talks on diverse topics, under the theme ‘Her Journey… Our Mission’.
The programme will highlight important issues pertaining to women’s health across every stage of life.
Organised by BDA, the Bahrain Obstetrics and Gynaecology Association and Bahrain Medical Society, the conference is timely and in response to the growing focus on women’s health as a fundamental pillar of family and community well-being in the kingdom.
Designed for obstetricians and gynecologists, family physicians, medical students, allied healthcare professionals and all individuals, the conference aims to provide a comprehensive scientific platform to discuss key challenges affecting women, from fertility and infertility to pregnancy and childbirth, and menopause and post-menopausal health.
“The event is expected to witness broad participation from a wide range of specialties, including psychiatry, pediatrics, breast surgery, nutrition, healthy lifestyle medicine, dermatology and diagnostic imaging,” conference chairperson and Bahrain Obstetrics and Gynaecology Association president Dr Nouf Behzad said.
She highlighted that the multidisciplinary approach goes beyond gynaecology alone, extending to physical, psychological, social and preventive aspects of care.
The conference will also highlight a critically-important aspect of daily obstetrics and gynaecology practice: medico-legal considerations and healthcare quality.
Given the unique challenges associated with maternal and fetal safety, clinical decision-making during critical situations, medical documentation and effective communication with patients and their families, dedicated sessions will address the importance of adherence to clinical protocols and professional standards, strengthening a culture of quality and patient safety, and minimising medical risks.
According to latest figures, dated 2023, the National Health Regulatory Authority received 210 complaints, with 32 against obstetrics and gynaecologists. These discussions aim to support physicians in delivering safe, evidence-based care while safeguarding the rights of both patients and healthcare providers.
Scientific Committee chairperson Dr Fatima Al Khan emphasised that the conference programme will feature multiple themes and tracks within the field of obstetrics and gynaecology. The event will also showcase healthcare companies and institutions, who will display the latest services, products and technologies in the field, further strengthening communication between the medical sector and supporting healthcare industries, while also creating opportunities for collaboration and knowledge exchange.
Last year, more than 40 local and international doctors and top medical professions shed light on diverse topics, including management of epilepsy during pre-contraception, pregnancy and post-partum periods, autoimmune disorders management in pregnancy and the cosmetic and aesthetic gynaecology.
Other discussions spanned burning issues like women’s care after 40, challenges in current medical treatment of endometriosis, selecting the most effective and contraception methods and understanding Polycystic Ovary Syndrome (PCOS) in adolescence.
Earlier this month, PCOS was renamed to polyendocrine metabolic ovarian syndrome (PMOS), which was decided by a global coalition of patients, clinicians and medical organisations to better reflect the condition’s wide-ranging hormonal and metabolic impacts. The disorder affects 170 million women worldwide and is the leading cause of infertility.
While the condition is not curable, symptoms are treatable with medications and changes in diet and exercise, according to the Endocrine Society, which include irregular or absent menstrual cycles, infertility, pregnancy complications, excess hair growth, acne, anxiety and depression, weight gain, obesity, diabetes and other disturbances in insulin, and cardiovascular disease.
Plans to transition to the new terminology over the next three years are already in motion, including integrating PMOS into health systems, clinical guidelines, professional training, and disease classification, researchers have said.
melissa@gdnmedia.bh
&uuid=(email))